Abstract:Objective: To study the effect of Danhong injection combined with valsartan on chronic renal failure and its related factors. Methods: 90 patients of chronic renal failure received therapy from March 2015 to March 2016 in our hospital were selected as research objects. According to the draw method divided into control group(n=45) and treatment group(n=45). Two groups of patients were treated with conventional treatment. The control group was treated with valsartan, 80mg per day, once a day. While the treatment group, on the basis of control group, treated with Danhong injection, 40mg per day, Add 5% glucose injection 200mL and mix intravenously, once a day. The two groups were treated for one month. Then treatment effect, clinical symptom score, renal function index, the level of 24 h urinary albumin (UAE), blood urea nitrogen (BUN), serum creatinine (SCr), the serum level of TGF-1, beta 1, VEGF, MCP-1, ANG II of two groups were compared. Results: The total effective rate of the treatment group was significantly higher than that of the control group(P<0.05); Lassitude, anorexia, clear night urine scores were significantly lower than the control group(P<0.05); The levels of UAE, BUN and Cr were significantly lower than those of the control group(P<0.05); The levels of TGF-1, beta 1, VEGF, MCP-1 and ANG II were significantly lower than those of the control group(P<0.05). Conclusion: Danhong injection combined with valsartan is well for chronic renal failure, which can improve the clinical symptoms, reduce urinary protein, improve the microcirculation of the kidney, and protect the renal function. It can significantly reduce the levels of serum TGF-β1, VEGF, MCP-1, ANG II, and alleviate the development of the disease.
王利平, 吴刚, 廖志敏, 赵城志, 黄洋辉. 丹红注射液联合缬沙坦对慢性肾衰竭患者的疗效及相关因子的影响[J]. 河北医学, 2018, 24(7): 1078-1080.
WANG Liping, WU Gang, LIAO Zhimin, et al. Effect of Danhong Injection combined with Valsartan on Efficacy and Related Factors in Patients with Chronic Renal Failure. HeBei Med, 2018, 24(7): 1078-1080.